[1] |
Krueger GG, Langley RG, Leonardi C, et al. A human interleukin⁃12/23 monoclonal antibody for the treatment of psoriasis[J]. N Engl J Med, 2007, 356(6): 580⁃592. DOI: 10.1056/NEJMoa062382.
|
[2] |
Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis[J]. Nature, 2007, 445(7130): 866⁃873. DOI: 10. 1038/nature05663.
|
[3] |
Ratner M. IL⁃17⁃targeting biologics aim to become standard of care in psoriasis[J]. Nat Biotechnol, 2015, 33(1): 3⁃4. DOI: 10.1038/nbt0115⁃3.
|
[4] |
Schmitz J, Owyang A, Oldham E, et al. IL⁃33, an interleukin⁃1⁃like cytokine that signals via the IL⁃1 receptor⁃related protein ST2 and induces T helper type 2⁃associated cytokines[J]. Immunity, 2005, 23(5): 479⁃490. DOI: 10.1016/j.immuni.2005.09.015.
|
[5] |
Hueber AJ, Alves⁃Filho JC, Asquith DL, et al. IL⁃33 induces skin inflammation with mast cell and neutrophil activation[J]. Eur J Immunol, 2011, 41(8): 2229⁃2237. DOI: 10.1002/eji. 201041360.
|
[6] |
Liu J. Pharmacology of oleanolic acid and ursolic acid[J]. J Ethnopharmacol, 1995, 49(2): 57⁃68.
|
[7] |
Liobikas J, Majiene D, Trumbeckaite S, et al. Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria[J]. J Nat Prod, 2011, 74(7): 1640⁃1644. DOI: 10.1021/np200060p.
|
[8] |
Checker R, Sandur SK, Sharma D, et al. Potent anti⁃inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF⁃κB, AP⁃1 and NF⁃AT[J]. PLoS One, 2012, 7(2): e31318. DOI: 10.1371/journal.pone.0031318.
|
[9] |
Shanmugam MK, Dai X, Kumar AP, et al. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies[J]. Biochem Pharmacol, 2013, 85(11): 1579⁃1587. DOI: 10.1016/j.bcp.2013.03.006.
|
[10] |
Ikeda Y, Murakami A, Fujimura Y, et al. Aggregated ursolic acid, a natural triterpenoid, induces IL⁃1beta release from murine peritoneal macrophages: role of CD36[J]. J Immunol, 2007, 178(8): 4854⁃4864.
|
[11] |
王刚. 银屑病免疫学研究新进展[J]. 中华皮肤科杂志, 2015, 48(4): 223⁃226. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.04. 001.
|
|
Wang G. Advances in the immunology of psoriasis[J]. Chin J Dermatol, 2015, 48(4): 223⁃226. DOI: 10.3760/cma.j.issn.0412⁃4030.2015.04.001.
|
[12] |
宋向凤, 田中伟. IL⁃33与皮肤炎症性疾病关系的研究进展[J]. 细胞与分子免疫学杂志, 2014, 30(9): 1000⁃1003. DOI: 10. 13423/j.cnki.cjcmi.007107.
|
|
Song XF, Tian ZW. Advances in the correlation between interleukin⁃33 and skin inflammatory disease[J]. Chin J Cell Mol Immunol, 2014, 30(9): 1000⁃1003. DOI: 10.13423/j.cnki.cjcmi.007107.
|
[13] |
Xu D, Jiang HR, Kewin P, et al. IL⁃33 exacerbates antigen⁃induced arthritis by activating mast cells[J]. Proc Natl Acad Sci USA, 2008, 105(31): 10913⁃10918. DOI: 10.1073/pnas. 0801898105.
|
[14] |
Moussion C, Ortega N, Girard JP. The IL⁃1⁃like cytokine IL⁃33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ′alarmin′?[J]. PLoS One, 2008, 3(10): e3331. DOI: 10.1371/journal.pone.0003331.
|
[15] |
Meephansan J, Tsuda H, Komine M, et al. Regulation of IL⁃33 by IFN⁃γ and tumor necrosis factor⁃α in normal human epidermal keratinocytes[J]. J Invest Dermatol, 2012, 132(11): 2593⁃2600. DOI: 10.1038/jid.2012.185.
|
[16] |
Ikeda Y, Murakami A, Ohigashi H. Ursolic acid: an anti⁃ and pro⁃inflammatory triterpenoid[J]. Mol Nutr Food Res, 2008, 52(1): 26⁃42. DOI: 10.1002/mnfr.200700389.
|
[17] |
You HJ, Choi CY, Kim JY, et al. Ursolic acid enhances nitric oxide and tumor necrosis factor⁃alpha production via nuclear factor⁃kappaB activation in the resting macrophages[J]. FEBS Lett, 2001, 509(2): 156⁃160. DOI: 10.1016/S0014⁃5793(01)03161⁃1.
|
[18] |
Ma JQ, Ding J, Zhang L, et al. Ursolic acid protects mouse liver against CCl4⁃induced oxidative stress and inflammation by the MAPK/NF⁃κB pathway[J]. Environ Toxicol Pharmacol, 2014, 37(3): 975⁃983. DOI: 10.1016/j.etap.2014.03.011.
|
[19] |
Yoon JH, Youn K, Ho CT, et al. p⁃Coumaric acid and ursolic acid from corni fructus attenuated β⁃amyloid(25⁃35)⁃induced toxicity through regulation of the NF⁃κB signaling pathway in PC12 cells[J]. J Agric Food Chem, 2014, 62(21): 4911⁃4916. DOI: 10.1021/jf501314g.
|
[20] |
Li N, McLaren JE, Michael DR, et al. ERK is integral to the IFN⁃γ⁃mediated activation of STAT1, the of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages[J]. J Immunol, 2010, 185(5): 3041⁃3048.DOI: 10.4049/jimmunol.1000993.
|